WHO ICTRP trial
To explore the predictive genes of treatment response for ankylosing spondylitis…
ChiCTR2400088487 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400088487 |
|---|---|
| Public title | To explore the predictive genes of treatment response for ankylosing spondylitis with TNF-a inhibitors and IL-17A inhibitors |
| Scientific title | To explore the predictive genes of treatment response for ankylosing spondylitis with TNF-a inhibitors and IL-17A inhibitors |
| Primary sponsor | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 1 |
| Countries | China |
| Conditions | ankylosing spondylitis |
| Interventions | Adalimumab group (Adalimumab injection):None;Secukinumab group (Secukinumab Injection):None |
| Registration date | Aug 20, 2024 |
| Target size | Adalimumab group (Adalimumab injection):22;Secukinumab group (Secukinumab… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: